Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.adv9403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Amit Manhas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Ion Channels, Protein Kinase Inhibitors, Cardiotoxicity, Cardiotonic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Tyrosine kinase inhibitors (TKIs) have improved cancer outcomes but are limited by cardiovascular toxicity, most notably hypertension and heart failure. The underlying mechanisms remain poorly understood, hindering the development of protective strategies. Here, we investigated the role of endothelial mechanotransduction in mediating vascular and cardiac injury caused by the vascular endothelial growth factor receptor–targeting TKI sunitinib. Using patient-specific induced pluripotent stem cell–derived endothelial cells (iPSC-ECs) and a mouse model of TKI-induced hypertension, we identified down-regulation of piezo-type mechanosensitive ion channel component 1 ( PIEZO1 ), a mechanically activated ion channel, as a driver of endothelial dysfunction. Restoring PIEZO1 expression, either pharmacologically with Yoda1, a selective agonist, or through inducible overexpression in iPSC-ECs, reversed sunitinib-induced endothelial dysfunction and mitigated its hypertensive effects, providing both mechanistic and genetic validation of PIEZO1’s protective role against vascular toxicity. In mice, cotreatment with sunitinib and Yoda1 prevented the long-term cardiac dysfunction observed after sunitinib exposure and normalized elevations in circulating cardiac stress biomarkers. Single-nucleus multiomic profiling of mouse hearts revealed that sunitinib exposure activated chromatin remodeling and fibrogenic programs, which were reversed with PIEZO1 activation. Human engineered cardiac organoids further demonstrated that sunitinib impaired cardiomyocyte function only in the presence of endothelial cells, confirming a role for disrupted endothelial-cardiomyocyte cross-talk in TKI cardiotoxicity. Together, these findings identify endothelial PIEZO1 as a mediator of TKI-induced hypertension and cardiac dysfunction and highlight PIEZO1 activation as a potential therapeutic strategy for protecting cardiovascular health during cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Medicine, Division of Cardiology, and Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
ORCID-Profile: Amit Manhas, Yu Liu, Chikage Noishiki, David Wu, Sarah Mirza, Dilip Thomas, Lu Liu, Avirup Guha, Patricia K Nguyen, Vipul Chitalia, Paul Cheng, Melinda L Telli, Joseph C Wu, Nazish Sayed
Förderung
- American Heart Association-American Stroke Association
- NHLBI NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Manhas, A., Liu, Y., Noishiki, C., Wu, D., Tripathi, D., Mirza, S., Thomas, D., Liu, L., Guha, A., Nguyen, P. K., Chen, I. Y., Chitalia, V., Cheng, P., Sayed, D., Telli, M. L., Sallam, K., Wu, J. C., & Sayed, N. (2025). Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adv9403
Vancouver
Manhas A, Liu Y, Noishiki C, Wu D, Tripathi D, Mirza S, et al. Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adv9403
BibTeX
@article{Manhas2025,
author = {Manhas, Amit and Liu, Yu and Noishiki, Chikage and Wu, David and Tripathi, Dipti and Mirza, Sarah and Thomas, Dilip and Liu, Lu and Guha, Avirup and Nguyen, Patricia K and Chen, Ian Y and Chitalia, Vipul and Cheng, Paul and Sayed, Danish and Telli, Melinda L and Sallam, Karim and Wu, Joseph C and Sayed, Nazish},
title = {Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.adv9403}
}
EUVIMED